Women with Factor V Leiden are at an increased risk of developing blood clots, particularly during periods of hormonal changes such as pregnancy, use of oral contraceptives, or hormone replacement therapy (HRT). These conditions can exacerbate the risk of venous thromboembolism (VTE), which includes both deep vein thrombosis (DVT) and pulmonary embolism (PE).
